News

Experts from the Violence Intervention Advocacy Program of the Boston Medical Center share insight from their research examining the spike of violence observed early in the COVID-19 pandemic.

An increase in annual prevalence of beneficiaries with diabetes was observed in those who had ≥1 claim for DME (1.0% to 3.3%) and DME/VTDR (2.8% to 4.3%).

Side effects of the vaccines occurred at a lower incidence in the current study.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 5, 2021.

AGN-190584 showed superiority in efficacy over vehicle in mesopic DCNVA on day 30 with an acceptable safety profile for patients with presbyopia.

Dr. Granger discusses the current underuse of these agents and the steps cardiologists need to take to increase prescription rates and uptake for patients.

HCV genotype 4 non-a/d subtypes are common in sub-Saharan Africa.

Investigators hoped that this knowledge would help formulate proper precautionary protocols that could promote mask usage for prolonged periods of time.

In an interview, lead investigator and expert Dr. Martin Kolb discusses his new phase 2b HZN-825 trial and what it's like treating the rare disease.

Dr. Pagidipati highlights her own approach to weight management, from lifestyle changes, diet, and medication to metabolic procedures.

Patients with psoriasis slept 1 hour less than control subjects, and associations with anxiety and depression were observed.

The American College of Rheumatology (ACR) has published guidance regarding the management of juvenile idiopathic arthritis, with emphasis placed on the treatment of systemic JIA and oligoarthritis, as well as non-pharmacologic therapies.

Patients with diarrhea did have longer hospital stays than patients without diarrhea.

The University of Colorado expert joins for a 5-part interview on making sense of the boom of new agents and care strategies.

There was a 2.4-fold increase in cancer among patients with pediatric-onset inflammatory bowel disease.

The Yale Associate Chief of Cardiovascular Medicine discusses improved use of available drug classes, as well as the potential approval for omecamtiv mecarbil.

While rates have increased in Finland since 1996, the societal costs have decreased in recent years thanks to a national sleep apnea initiative.

African American individuals and Hispanic individuals were more likely than non-Hispanic White individuals to report not being able to afford medications.

From a couple of novel heart failure treatments to a promising dual receptor agonist, here's a rundown of expected pipeline news this year in heart disease.

The American College of Rheumatology releases 2 new guidelines for treating patients with juvenile idiopathic arthritis.

Virk will chair a discussion on depression treatments on March 3.

The novel technology combines daily disposable contact lenses with ketotifen in a first in its new category approval.

When the pandemic began, prescribers in Canada were allowed to increase the amount of opioid agonist therapy take-home doses for individuals with opioid use disorder.

Aspartyl-alanyl-diketopiperazine (Ampion), an intra-articular injection, works to regulate immune responses that are connected to pain, inflammation, and joint damage in patients with osteoarthritis of the knee.

Dr. Obi speaks of the disparities associated with the disease, the challenges patients face, and how sarcoidosis – the “great mimicker” as some clinicians have described it- can be differentiated from other diseases.

Influenza mortality rates have not been updates since the last estimate in 2009.

The Johns Hopkins expert details recent advances in remote cardiovascular care and research, and explains how the field will continue to evolve.

In rheumatoid arthritis, a treat-to-target approach aims for remission or low disease activity within the first 3 months. However, investigators noted that improvements continued to increase throughout the 52-week period.

Though atopic dermatitis is linked to sleep disturbance, the exact timing of weekday versus weekend sleep and light exposure have not been evaluated.